IRadimed Corporation
IRMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $0 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 11.7% | 23% | 27.5% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 76.9% | 76.5% | 77.4% | 76.6% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 31.1% | 31.7% | 30.6% | 26.8% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 26.3% | 26.2% | 24.1% | 22.3% |
| EPS Diluted | 1.5 | 1.35 | 1.02 | 0.74 |
| % Growth | 11.1% | 32.4% | 37.8% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |